查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566838

血糖監測設備市場：按設備、患者類型和最終用戶分類：2024-2033 年全球機會分析和產業預測

Glucose Monitoring Devices Market By Device, By Patient Type By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 216 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

血糖監測設備市場

2023年，血糖監測設備市場價值為147億美元，預計2024年至2033年複合年成長率為10.2%，到2033年達到389億美元。

血糖監測涉及測量和追蹤個體血液或組織液中的血糖濃度。它是有效管理糖尿病患者的重要常規，因為它提供全天血糖值波動的資料，以響應飲食攝取、壓力、體力活動和藥物等多種因素。血糖監測設備的即時或定期血糖讀數使您能夠就飲食選擇、藥物劑量和生活方式調整做出明智的決定。血糖監測設備是預防與糖尿病相關的短期和長期併發症的重要設備。

肥胖和糖尿病等與文明病盛行率不斷上升，是血糖監測設備市場的主要促進因素。此外，個人對自我監控行動裝置的需求正在迅速增加，這有助於開拓市場。目前，非侵入性血糖監測設備是市場的趨勢。光學感測器和微針貼片是市場上最常見的設備之一。此外，資料分析的整合正在受到個人和醫療保健提供者的關注，因為它有助於識別模式和趨勢，從而有助於主動的疾病管理和預防。

然而，由於血糖測試結果的高可靠性，許多人堅持傳統的血糖測試方法，這對新型和創新的血糖監測設備的廣泛採用提出了挑戰。此外，新監控設備的核准過程非常嚴格且耗時，往往會延遲新產品推向市場的時間。相較之下，科學家不斷努力推出創新產品，為市場擴張提供了有利可圖的機會。例如，沙烏地阿拉伯阿卜杜拉國王科技大學的研究人員開發了一種原型感測器，可以使用唾液測量血糖濃度。預計該設備未來將成為個人測量血糖值的簡單、快速、無痛的方式。

按部門審查

血糖監測設備市場分為設備、患者類型、最終用戶和地區。依裝置分為血糖儀、連續血糖監測系統、快速血糖監測系統、智慧型手機應用程式和穿戴式裝置。依患者類型分為第1型糖尿病和第2型糖尿病。依最終使用者分類，可分為醫院/診所、居家照護環境等。從區域來看，分析涵蓋北美、歐洲、亞太地區和拉丁美洲/中東/非洲。

主要發現

按設備分類，連續血糖監測設備領域在 2023 年的市場收益最高。

按患者類型分類，1 型糖尿病細分市場將成為 2023 年的最大股東。

按最終用戶分類，居家照護細分市場 2023 年收益最高。

可以使用此報告進行客製化（需要額外費用和時間表）

  • 監管指引
  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 擴大公司簡介列表
  • 歷史市場資料

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 關鍵投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章血糖監測設備市場：依設備分類

  • 市場概況
  • 血糖儀
  • 連續血糖監測裝置
  • 快速血糖監測裝置
  • 智慧型手機應用程式和穿戴式裝置

第5章血糖監測設備市場：依患者類型

  • 市場概況
  • 1型糖尿病
  • 2型糖尿病

第6章血糖監測設備市場：依最終用戶分類

  • 市場概況
  • 醫院和診所
  • 居家醫療
  • 其他

第7章血糖監測設備市場：按地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國血糖監測設備市場
    • 加拿大血糖監測設備市場
    • 墨西哥血糖監測設備市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 法國血糖監測設備市場
    • 德國血糖監測設備市場
    • 義大利血糖監測設備市場
    • 西班牙血糖監測設備市場
    • 英國血糖監測設備市場
    • 其他歐洲血糖監測設備市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 中國血糖監測設備市場
    • 日本血糖監測設備市場
    • 印度血糖監測設備市場
    • 韓國血糖監測設備市場
    • 澳洲血糖監測設備市場
    • 其他亞太地區血糖監測設備市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西血糖監測設備市場
    • 南非血糖監測設備市場
    • 沙烏地阿拉伯血糖監測設備市場
    • 其他拉丁美洲/中東/非洲血糖監測設備市場

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第9章 公司簡介

  • Menarini Diagnostics SRL
  • Senseonics, A.
  • Novo Nordisk A/S
  • GlySens Incorporated
  • Johnson And Johnson
  • DexCom, Inc.
  • Medtronic Plc
  • F. Hoffman-La Roche Ltd
  • Abbott Laboratories
  • B. Braun SE
簡介目錄
Product Code: A62953

Glucose Monitoring Devices Market

The glucose monitoring devices market was valued at $14.7 billion in 2023 and is projected to reach $38.9 billion by 2033, growing at a CAGR of 10.2% from 2024 to 2033.

Glucose monitoring involves the measuring and tracking the glucose levels in the blood or interstitial fluid of individuals. It is an essential routine for individuals with diabetes for effective management, as it provides data about fluctuations in blood sugar levels throughout the day in response to several factors such as food intake, stress, physical activity, and medication. The real-time or periodic glucose readings provided glucose monitoring devices allow individuals to make informed decisions regarding dietary choices, medication dosage, and lifestyle adjustments. Glucose monitoring devices are critical equipment for the prevention of short-term and long-term complications associated with diabetes.

Increase in prevalence of lifestyle diseases, including obesity and diabetes, is a major driver of the glucose monitoring devices market. In addition, the demand for self-monitoring portable devices is surging among individuals, hence augmenting the development of the market. Non-invasive glucose monitoring devices are trending in the market currently. Optical sensors and microneedle patches are among the most common equipment available in the market. Furthermore, the integration of data analytics is acquiring traction from individuals and healthcare providers as it aids to identify patterns and trends, thereby assisting in proactive management and prevention of diseases.

However, a large base of individuals adheres to the traditional method of glucose testing owing to high confidence in its results, which presents challenges for the widespread adoption of new & innovative glucose monitoring devices. Moreover, the approval process of new monitoring devices is highly stringent and lengthy, which often delays the introduction of novel products into the market. Contrarily, the constant efforts of scientists to launch innovative products present lucrative opportunities for the expansion of the market. For instance, researchers of the King Abdullah University of Science & Technology, Saudi Arabia developed a prototype for a sensor that measures glucose levels using saliva. This device is projected to be a simple, quick, and painless way for individuals to measure blood glucose in the future.

Segment Review

The glucose monitoring devices market is segmented into device, patient type, end user, and region. On the basis of device, the market is divided into blood glucose meters, continuous glucose monitoring systems, flash glucose monitoring systems, smartphone apps, and wearables. By patient type, it is bifurcated into type 1 diabetes and type 2 diabetes. According to end user, it is classified into hospitals & clinics, home care settings, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of device, the continuous glucose monitoring devices segment generated the highest revenue in the market in 2023.

By patient type, the type 1 diabetes segment was the highest shareholder in 2023.

According to end user, the home care settings segment was the highest revenue generator in 2023.

Competition Analysis

The major players operating in the global glucose monitoring devices market include Menarini Diagnostics S.R.L., Senseonics, A., Novo Nordisk A/S, GlySens Incorporated, Johnson & Johnson, DexCom, Inc., Medtronic plc, F. Hoffman-La Roche Ltd, Abbott laboratories, and B. Braun SE. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Device

  • Blood Glucose Meters
  • Continuous Glucose Monitoring Systems
  • Flash Glucose Monitoring Systems
  • Smartphone Apps and Wearables

By Patient Type

  • Type 1 Diabetes
  • Type 2 Diabetes

By End User

  • Hospitals and Clinics
  • Home Care Settings
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Menarini Diagnostics S.R.L.
    • Senseonics, A.
    • Novo Nordisk A/S
    • GlySens Incorporated
    • Johnson & Johnson
    • DexCom, Inc.
    • Medtronic plc
    • F. Hoffman-La Roche Ltd
    • Abbott laboratories
    • B. Braun SE

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.5. Market Dynamics
    • 3.5.1. Drivers
    • 3.5.2. Restraints
    • 3.5.3. Opportunities

CHAPTER 4: GLUCOSE MONITORING DEVICES MARKET, BY DEVICE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Device
  • 4.2. Blood Glucose Meters
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Continuous Glucose Monitoring Systems
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Flash Glucose Monitoring Systems
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Smartphone Apps And Wearables
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country

CHAPTER 5: GLUCOSE MONITORING DEVICES MARKET, BY PATIENT TYPE

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Patient Type
  • 5.2. Type 1 Diabetes
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Type 2 Diabetes
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: GLUCOSE MONITORING DEVICES MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals And Clinics
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Home Care Settings
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: GLUCOSE MONITORING DEVICES MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Device
    • 7.2.3. Market Size and Forecast, By Patient Type
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Glucose Monitoring Devices Market
      • 7.2.6.1. Market Size and Forecast, By Device
      • 7.2.6.2. Market Size and Forecast, By Patient Type
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Glucose Monitoring Devices Market
      • 7.2.7.1. Market Size and Forecast, By Device
      • 7.2.7.2. Market Size and Forecast, By Patient Type
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Glucose Monitoring Devices Market
      • 7.2.8.1. Market Size and Forecast, By Device
      • 7.2.8.2. Market Size and Forecast, By Patient Type
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Device
    • 7.3.3. Market Size and Forecast, By Patient Type
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Glucose Monitoring Devices Market
      • 7.3.6.1. Market Size and Forecast, By Device
      • 7.3.6.2. Market Size and Forecast, By Patient Type
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Glucose Monitoring Devices Market
      • 7.3.7.1. Market Size and Forecast, By Device
      • 7.3.7.2. Market Size and Forecast, By Patient Type
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Glucose Monitoring Devices Market
      • 7.3.8.1. Market Size and Forecast, By Device
      • 7.3.8.2. Market Size and Forecast, By Patient Type
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Glucose Monitoring Devices Market
      • 7.3.9.1. Market Size and Forecast, By Device
      • 7.3.9.2. Market Size and Forecast, By Patient Type
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Glucose Monitoring Devices Market
      • 7.3.10.1. Market Size and Forecast, By Device
      • 7.3.10.2. Market Size and Forecast, By Patient Type
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Glucose Monitoring Devices Market
      • 7.3.11.1. Market Size and Forecast, By Device
      • 7.3.11.2. Market Size and Forecast, By Patient Type
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Device
    • 7.4.3. Market Size and Forecast, By Patient Type
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Glucose Monitoring Devices Market
      • 7.4.6.1. Market Size and Forecast, By Device
      • 7.4.6.2. Market Size and Forecast, By Patient Type
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Glucose Monitoring Devices Market
      • 7.4.7.1. Market Size and Forecast, By Device
      • 7.4.7.2. Market Size and Forecast, By Patient Type
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Glucose Monitoring Devices Market
      • 7.4.8.1. Market Size and Forecast, By Device
      • 7.4.8.2. Market Size and Forecast, By Patient Type
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Glucose Monitoring Devices Market
      • 7.4.9.1. Market Size and Forecast, By Device
      • 7.4.9.2. Market Size and Forecast, By Patient Type
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Glucose Monitoring Devices Market
      • 7.4.10.1. Market Size and Forecast, By Device
      • 7.4.10.2. Market Size and Forecast, By Patient Type
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Glucose Monitoring Devices Market
      • 7.4.11.1. Market Size and Forecast, By Device
      • 7.4.11.2. Market Size and Forecast, By Patient Type
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Device
    • 7.5.3. Market Size and Forecast, By Patient Type
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Glucose Monitoring Devices Market
      • 7.5.6.1. Market Size and Forecast, By Device
      • 7.5.6.2. Market Size and Forecast, By Patient Type
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Glucose Monitoring Devices Market
      • 7.5.7.1. Market Size and Forecast, By Device
      • 7.5.7.2. Market Size and Forecast, By Patient Type
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Glucose Monitoring Devices Market
      • 7.5.8.1. Market Size and Forecast, By Device
      • 7.5.8.2. Market Size and Forecast, By Patient Type
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Glucose Monitoring Devices Market
      • 7.5.9.1. Market Size and Forecast, By Device
      • 7.5.9.2. Market Size and Forecast, By Patient Type
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Menarini Diagnostics S.R.L.
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Senseonics, A.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Novo Nordisk A/S
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. GlySens Incorporated
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Johnson And Johnson
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. DexCom, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Medtronic Plc
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. F. Hoffman-La Roche Ltd
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Abbott Laboratories
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. B. Braun SE
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments